Table 1.
The clinical characteristics of the two groups
| Variables | IVC (n = 57) |
IVC + RA (n = 18) |
p |
|---|---|---|---|
| Age (years) | 54.6 ± 10.6 | 51.9 ± 10.3 | 0.340 |
| Gender | |||
| Male | 50 (87.7%) | 16 (88.9%) | 0.631 |
| Female | 7 (12.3%) | 2 (11.1%) | |
| Performance status | |||
| 0 | 14 (24.6%) | 3 (16.7%) | 0.543 |
| 1 | 43 (75.4%) | 15 (83.3%) | |
| Child-Pugh classification | |||
| A | 51 (89.5%) | 15 (83.3%) | 0.678 |
| B | 6 (10.5%) | 3 (16.7%) | |
| Intrahepatic tumor number | |||
| Solitary | 43 (75.4%) | 11 (61.1%) | 0.238 |
| Multiple | 14 (24.6%) | 7 (38.9%) | |
| LN metastases | |||
| Absent | 53 (93.0%) | 15 (83.3%) | 0.348 |
| Present | 4 (7.0%) | 3 (16.7%) | |
| Distant metastases | |||
| Absent | 44 (77.2%) | 10 (55.6%) | 0.075 |
| Present | 13 (22.8%) | 8 (44.4%) | |
| HBsAg | |||
| Negative | 5 (8.8%) | 1 (5.6%) | 0.555 |
| Positive | 52 (91.2%) | 17 (94.4%) | |
| AFP (μg/L) | |||
| < 400 | 31 (54.4%) | 13 (72.2%) | 0.180 |
| ≥ 400 | 26 (45.6%) | 5 (27.8%) | |
| No. of prior therapies | 3.7 ± 1.5 | 4.1 ± 1.7 | 0.407 |
Abbreviations: IVC inferior vena cava, RA right atrium, LN lymphonodus, AFP α-fetoprotein